Collegium Pharmaceutical, Inc. COLL Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s interest paid?
- Collegium Pharmaceutical, Inc. (COLL) reported interest paid of $22.11M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s interest paid changed year-over-year?
- Collegium Pharmaceutical, Inc.'s interest paid increased by 1.9% year-over-year, from $21.69M to $22.11M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s interest paid?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s interest paid has grown at a 40.6% compound annual growth rate (CAGR), from $17.61M to $68.76M.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.